Close
CDMO Safety Testing 2026
Novotech

News

Novo Nordisk OpenAI Partnership Accelerates Drug Development

Danish pharmaceutical major Novo Nordisk has entered into a strategic collaboration with OpenAI to embed artificial intelligence across its drug development operations, with the stated goal of accelerating the delivery of new treatments. Announced on Tuesday, the initiative is...

Are Pharma Grade Supplement Powders Produced Differently than Food Grade?

The supplement industry has experienced exponential growth over the past decade, with consumers becoming increasingly discerning about the quality and purity of the products they consume. As nutritional supplements have evolved from niche products to mainstream health essentials, questions...

Understanding Bacterial Infections: Causes, Signs, and Care

Bacterial infections are a very common, neglected health concern which can go unnoticed in early stages and affect people of all ages. The immune system plays an important role in identifying harmful pathogens, defending the body against invasion, and...

Tubilux Pharma Upgrades with Steriline Aseptic Filling Line

Steriline has completed the delivery and installation of a fully integrated aseptic filling line at a manufacturing facility operated by Tubilux Pharma. The system is designed to process both plastic and glass vials, supporting applications ranging from eye drops...

Regeneron Telix Radiopharma Deal Targets Cancer Therapies

Regeneron Pharmaceuticals has entered into a strategic agreement with Telix Pharmaceuticals to jointly develop next-generation oncology treatments, in a deal valued at up to $2.1 billion in milestone payments. The radiopharma collaboration will combine Regeneronโ€™s antibody-based discovery capabilities with...

Overqualified and Underutilized: The Hidden Risk in Physician Hiring

Hospitals brag about โ€œtop talent,โ€ then act stunned when that talent starts shopping for the exit. The quiet disaster in physician hiring usually stems from something other than credential issues. It comes from an excess of them. A clinician...

Drug Manufacturing Deals Shift to Europe Despite Tariffs

Biopharma companies are continuing to redirect production strategies toward Europe, even as U.S. policymakers attempt to strengthen domestic output through tariffs and onshoring measures. According to GlobalData, the latest data highlights a clear divergence in deal activity, with drug...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป